• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Th


<























Similar threads